Cargando…

A Metabolic Activity Recovery of the Intestinal Microbiota in the Patients with Bronchial Asthma

BACKGROUND: It was established that the high biological diversity of intestinal microorganisms promotes the needed SCFAs production, which induces immune regulatory pathways and contributes to the anti-inflammatory response. Study. A group of 30 patients with allergic bronchial asthma (BA) were inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozimek, Mariusz, Ivashkin, Vladimir, Zolnikova, Oksana, Potskherashvili, Nino, Ivashkin, Konstantin, Dzhakhaya, Natiya, Kurbatova, Anastasia, Kryuchkova, Kira, Zaborova, Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553837/ https://www.ncbi.nlm.nih.gov/pubmed/36247882 http://dx.doi.org/10.1155/2022/9902438

Ejemplares similares

Metabolic activity of intestinal microflora in patients with bronchial asthma
por: Ivashkin, Vladimir, et al.
Publicado: (2019)

Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis
por: Maslennikov, Roman, et al.
Publicado: (2023)

The study of the relevance of macro- and microelements in the hair of young wrestlers depending on the style of wrestling
por: Zaborova, Victoria, et al.
Publicado: (2022)

Associations between Physical Activity and Kyphosis and Lumbar Lordosis Abnormalities, Pain, and Quality of Life in Healthy Older Adults: A Cross-Sectional Study
por: Zaborova, Victoria, et al.
Publicado: (2023)

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2018)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19)
por: Maslennikov, Roman, et al.
Publicado: (2021)

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2021)

Early viral versus late antibiotic-associated diarrhea in novel coronavirus infection
por: Maslennikov, Roman, et al.
Publicado: (2021)

Changes in kinesiostabilogram parameters and movement speed of stroke patients while increasing their physical activity due to the use of biofeedback method
por: Zaborova, Victoria, et al.
Publicado: (2021)

Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial
por: Maslennikov, Roman, et al.
Publicado: (2022)

Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome
por: Ivashkin, V., et al.
Publicado: (2021)

The Concept of Folic Acid in Health and Disease
por: Shulpekova, Yulia, et al.
Publicado: (2021)

Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
por: Mamieva, Zarina, et al.
Publicado: (2022)

Risk Factors for Locomotive Crew Members Depending on Their Place of Work
por: Zhidkova, Elena A., et al.
Publicado: (2022)

Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

On Bronchial Asthma
Publicado: (1890)

Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Sleep Disorders in Patients with Bronchial Asthma
por: Cukic, Vesna, et al.
Publicado: (2011)

Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
por: Maslennikov, Roman, et al.
Publicado: (2023)

Immune disorders and rheumatologic manifestations of viral hepatitis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Neurotrophins in bronchial asthma
por: Renz, Harald
Publicado: (2001)

The Treatment of Bronchial Asthma
Publicado: (1947)

Progenitors of the protochordate ocellus as an evolutionary origin of the neural crest
por: Ivashkin, Evgeniy, et al.
Publicado: (2013)

Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin)
por: Zaborova, Victoria, et al.
Publicado: (2023)

Nitric oxide therapy is beneficial to rehabilitation in professional soccer players: clinical and experimental studies
por: Zaborova, Victoria A., et al.
Publicado: (2022)

Subcutaneous Emphysema in Bronchial Asthma
por: Kernohan, R. J.
Publicado: (1956)

EMOTIONAL FACTORS IN BRONCHIAL ASTHMA
por: Desai, Nimesh G., et al.
Publicado: (1981)

MANIFEST ANXIETY IN BRONCHIAL ASTHMA
por: Sreedhar, Krishna Prasad
Publicado: (1989)

Bronchial Asthma and Pulmonary Tuberculosis
por: Ghosh, P. K.
Publicado: (1945)

Lettsomian Lectures on Bronchial Asthma
Publicado: (1885)

Soamin in the Treatment of Bronchial Asthma
por: Ghosh, B. N.
Publicado: (1918)

The Roles of Phytochemicals in Bronchial Asthma
por: Park, Hee Sun, et al.
Publicado: (2010)

Bronchial Asthma and Pulmonary Tuberculosis
por: Foggie, W. E.
Publicado: (1933)

The Role of Adrenoceptors in Bronchial Asthma
por: Patel, K. R.
Publicado: (1979)

Infection, asthma and bronchial hyperresponsiveness
por: Trigg, C.J., et al.
Publicado: (1993)

Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?
por: Maslennikov, Roman, et al.
Publicado: (2021)

Probiotics in hepatology: An update
por: Maslennikov, Roman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e0bis9esb6olvft3hbgu28ouqm